Transplantation Proceedings; Tekin S, Özdoğan H et. al.
Jan 16th, 2021 - Immunocompromised populations are at great risk of the current 2020 global emergency of coronavirus disease 2019 (COVID-19), and treatment of kidney transplant recipients with COVID-19 is currently not declared. Hence, the purpose of the study is to set a clear treatment regimen. We report here a therapeutic course of 2 patients who underwent transplant surgery in March 2020 and got infected so...
https://doi.org/10.1007/s10067-020-05572-9 10.1016/j.tmaid.2020.101788 10.1038/s41584-020-0372-x 10.1186/s42358-020-00134-8 10.1136/annrheumdis-2019-215089 10.1016/s0002-9343(99)80399-4 10.1186/ar2764 10.1186/ar2095 10.1016/j.ijantimicag.2007.05.015 10.1038/s41584-018-0111-8 10.1016/j.ejphar.2003.11.003 10.1080/15563650500514558 10.1093/aje/kwaa093 10.1093/cid/ciaa237 10.1038/s41467-020-17907-w 10.31083/j.rcm.2020.03.126 10.1016/j.tmaid.2020.101738 10.1016/j.ijantimicag.2020.106144 10.1016/j.numecd.2020.07.031 10.1016/j.ijid.2020.06.099 10.1016/j.tmaid.2020.101791 10.1007/s11739-020-02505-x 10.1371/journal.pone.0237693 10.1001/jama.2020.8630 10.1056/NEJMoa2012410 10.1158/2159-8290.CD-20-0941 10.1001/jamacardio.2020.1834 10.1016/j.therap.2020.05.002 10.1016/j.hrthm.2020.06.016 10.1080/07853890.2020.1790643 10.1056/NEJMoa2016638 10.1016/S2665-9913(20)30227-7
Clinical Rheumatology; Pothen L, Yildiz H et. al.
Jan 16th, 2021 - In the early stage of the COVID-19 pandemic, Belgian health authorities endorsed the interim guidelines for the treatment of COVID-19 pneumonia: hydroxychloroquine (HCQ) recommended for treatment of hospitalized patients with moderate to severe disease. As a growing number of patients were admitted, inevitably, our internal medicine team questioned the efficacy and safety of HCQ, especially wit...
International Journal of Chronic Obstructive Pulmonary Disease; Gómez Antúnez M, Muiño Míguez A et. al.
Jan 15th, 2021 - To describe the characteristics and prognosis of patients with COPD admitted to the hospital due to SARS-CoV-2 infection. The SEMI-COVID registry is an ongoing retrospective cohort comprising consecutive COVID-19 patients hospitalized in Spain since the beginning of the pandemic in March 2020. Data on demographics, clinical characteristics, comorbidities, laboratory tests, radiology, treatment,...
https://doi.org/10.1186/s12879-021-05773-w 10.1093/pan/mpl013 10.1007/s00281-017-0629-x 10.1016/S0140-6736(20)30183-5 10.1007/s00281-017-0640-2 10.1097/RCT.0000000000001075
BMC Infectious Diseases; Ip A, Ahn J et. al.
Jan 15th, 2021 - Hydroxychloroquine has not been associated with improved survival among hospitalized COVID-19 patients in the majority of observational studies and similarly was not identified as an effective prophylaxis following exposure in a prospective randomized trial. We aimed to explore the role of hydroxychloroquine therapy in mildly symptomatic patients diagnosed in the outpatient setting. We examined...
Journal of Cardiac Surgery REFERENCES; Cerillo AG, Marchionni N et. al.
Jan 14th, 2021 - We describe the baseline, operative, and postoperative features of a group of 18 patients who contracted the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection in a rehabilitation facility after cardiac surgery, and present some potential explanations for the surprisingly benign course of the COVID-19 in this cohort. All patients were operated on an urgent or emergency basis ...
Annals of Palliative Medicine; Chen S, Lin W et. al.
Jan 14th, 2021 - Many cases of novel coronavirus 2019 (COVID-19) have confirmed in many countries around the world. Due to the disorders of the immune system, diabetic patients are more likely to suffer from severe COVID-19. Glucagon-like peptide 1 receptor analogues (GLP-1R analogues) commonly can be used to reduce blood sugar. There is no clear evidence that it can be safely and effectively used in patients w...
Journal of the American Academy of Dermatology; Rangel LK, Shah P et. al.
Jan 13th, 2021 - Chronic Hydroxychloroquine Therapy and COVID-19 Outcomes: A Retrospective Case-Control Analysis.|2021|Rangel LK,Shah P,Lo Sicco K,Caplan AS,Femia A,|
Infectious Disorders Drug Targets; Karthika C, Sureshkumar R
Jan 12th, 2021 - The Covid-19 pandemic has become a major challenge for health care professionals and researchers all over the world. The discovery and development of new drugs require time for passing the quality, safety, and efficacy criteria. Hence the only available option is to rely on herbal or natural remedies as well as other existing ones. Nature has its healing power and has the remedy for all the ail...
Chest Odackal J, Milinic T et. al.
Jan 10th, 2021 - A 28-year-old man presented with shortness of breath, chest pain, and scant hemoptysis. Three weeks previously, he was admitted for coronavirus disease 2019 pneumonia that had been diagnosed by nasal swab polymerase chain reaction. Chest CT imaging demonstrated bilateral ground-glass opacities without evidence of VTE. He was treated with hydroxychloroquine, up to 7 L/min oxygen, and self-pronin...
Transplantation Proceedings; Silvano J, Ferreira F et. al.
Jan 9th, 2021 - Knowledge about the impact of coronavirus disease 2019 (COVID-19) on kidney transplant recipients (KTRs) concerning viral shedding and humoral immune response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is limited. The aim of this study is to analyze viral dynamics and the antibody response to SARS-CoV-2 in KTRs with COVID-19 and study their association with clinical da...
American Journal of Therapeutics; Shah S, Shah K et. al.
Jan 8th, 2021 - Effects of Hydroxychloroquine With or Without Azithromycin on QT Interval in COVID-19: A Systematic Review. Electrophysiology Collaborative Consortium for Meta-analysis-Electram Investigators.|2021|Shah S,Shah K,Turagam MK,Lakkireddy D,Garg J,|
Cardiology in the Young; Gokalp S, Çilsal E et. al.
Jan 7th, 2021 - An otherwise healthy 17-year-old adolescent boy presented with upper respiratory tract symptoms and was diagnosed with coronavirus disease 2019 infection. A haemorrhagic pericardial effusion was found in the transthoracic echocardiography. He was treated with pericardiocentesis, ibuprofen, and hydroxychloroquine. A large pericardial effusion may complicate COVID-19 in children and should be con...
Psychopharmacology Plasencia-García BO, Rodríguez-Menéndez G et. al.
Jan 7th, 2021 - Management of anxiety, delirium, and agitation cannot be neglected in coronavirus disease (COVID-19). Antipsychotics are usually used for the pharmacological management of delirium, and confusion and behavioral disturbances. The concurrent use of treatments for COVID-19 and antipsychotics should consider eventual drug-drug interactions OBJECTIVE: To systematically review evidence-based availabl...
BMC Public Health; Sadio AJ, Gbeasor-Komlanvi FA et. al.
Jan 7th, 2021 - To date, there is no effective treatment for COVID-19, which is a pandemic disease, caused by a novel coronavirus called SARS-CoV-2. In Togo, where four in five people practice self-medication, the absence of a cure for COVID-19 and the constant progression of the disease requires an assessment of self-medication patterns in the context of the pandemic. This study aimed to estimate the prevalen...
Clinical and Translational Science; Okada JI, Yoshinaga T et. al.
Jan 6th, 2021 - The risk of fatal arrhythmias is the major concern for using chloroquine (CQ) or hydroxychloroquine (HCQ) to treat coronavirus disease 2019 (COVID-19), but the reported number of life-threatening arrhythmic events or deaths is relatively small. The objective of this study was to assess the arrhythmogenic risk of these two drugs using a multi-scale heart simulation, which allows testing even at ...
The American Journal of Dermatopathology; Pezzarossa E, Ungari M et. al.
Jan 6th, 2021 - The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rapidly spreading throughout the world. The study describes 12 patients with SARS-CoV-2 pneumonia, who developed an acute erythematous rash with nonfollicular pinhead-sized pustules, without mucosal involvement. The clinical differential diagnosis was viral rash, acute general...
Current Rheumatology Reports; Fitzgerald GE, Maguire S et. al.
Jan 6th, 2021 - Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) emerged in December 2019, rapidly reaching global pandemic proportions. Coronavirus disease 2019 (COVID-19) has presented unique challenges to the rheumatology community. It is known that many individuals with rheumatic disease are at increased risk of severe disease from other infections, sparking a similar fear for COVID-19....
Dermatologic Therapy REFERENCES; Olds H, Liu J et. al.
Jan 6th, 2021 - Telogen effluvium (TE) is characterized by diffuse hair shedding 2-3 months after a stressor, and COVID-19 infection is potentially one such stressor. Those who were infected with the virus were under immense psychosocial and physiologic stress. We retrospectively reviewed electronic medical records of 552 patients who were evaluated by a Henry Ford Health System dermatologist between February ...
PloS One; Lewis K, Chaudhuri D et. al.
Jan 6th, 2021 - Populations such as healthcare workers (HCW) that are unable to practice physical distancing are at high risk of acquiring Coronavirus disease-2019 (COVID-19). In these cases pharmacological prophylaxis would be a solution to reduce severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) transmission. Hydroxychloroquine has in vitro antiviral properties against SARS CoV-2. We therefore sou...
Advances in Respiratory Medicine; Jindal V, Mittal S et. al.
Jan 4th, 2021 - Data regarding knowledge and attitude about COVID-19, the prevalence of acceptance of hydroxychloroquine prophylaxis and anxiety amidst COVID-19 pandemic among health care students/professionals in India is scarce. A cross-sectional study was conducted during May 2020, using an online survey via Google forms. A self-administered validated structured questionnaire was applied, which comprised 28...